FLUGEN, INC.

Biotechnology ResearchWisconsin, United States2-10 Employees

Flugen, Inc. is a clinical-stage biotechnology company based in Madison, Wisconsin, focused on developing vaccines to improve efficacy against respiratory diseases. The company aims to address gaps in protection offered by existing vaccines, leveraging its M2SR technology to advance vaccine performance in its programs. Its work targets the needs of patients and health systems facing seasonal and emerging respiratory threats, including influenza and COVID-19, with a pipeline that encompasses investigational vaccine candidates evaluated in human studies. FluGen operates within the biotechnology research sector, emphasizing translational development from research concepts to clinical-stage candidates.

Founded and positioned as a specialist in respiratory vaccines, FluGen collaborates within an ecosystem that supports scalable vaccine processes and clinical evaluation. The firm’s activities are centered in Madison, Wisconsin, and it has publicly announced progress on its M2SR platform and related vaccine candidates, including programs such as Bris2007 M2SR and efforts to study protection against drifted strains. As a small- to mid-sized player in a competitive field, FluGen maintains a focused portfolio aimed at advancing vaccines through early clinical milestones while pursuing partnerships and collaborations to validate its approach.

Sign up for free to view info

Email Format Employee directory